BPTF says FDA safety and innovation act is good for safety and US industry
SOCMA’s BPTF says new fee laws under the FDA Safety and Innovation Act will improve drug quality and boost US manufacturing sector.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs